Search - tctmd.com

Displaying 961 - 980 of 2846

Sort: Relevancy | Date

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

News Conference News AHA 2018

TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG

Shelley Wood

November 13, 2018

News Conference News AHA 2018

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

Michael O'Riordan

November 11, 2018

News Conference News AHA 2018

Endoscopic Vein-Graft Harvest for CABG Associated With Similar MACE, Less Pain vs Open Procedure: REGROUP

Yael L. Maxwell

November 11, 2018

News Conference News AHA 2018

Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients

Caitlin E. Cox

November 11, 2018

News Conference News AHA 2018

T-Time: Alteplase Infusion No Help for Failed Reperfusion in STEMI PCI

Shelley Wood

November 11, 2018

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Conference News AHA 2018

REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides

Todd Neale

November 10, 2018

News Conference News AHA 2018

VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer

Shelley Wood

November 10, 2018

News Daily News

Race May Be a Proxy for Many Disparities in CVD Treatment, Outcomes

Yael L. Maxwell

November 07, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Daily News

High-Sensitivity Troponin Assays May Help Cut Down on Unnecessary Stress Tests, Study Suggests

Todd Neale

November 05, 2018

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

News Daily News

Lingering Signs of Inflammation Post-PCI Signal More Death, MI at 1 Year

Caitlin E. Cox

October 31, 2018

News Opinion Fellow Talk

A Look Back at TCT 2018: What I Took Away From the Meeting

Yashasvi Chugh, MD

October 23, 2018

News Daily News

Bariatric Surgery Reduces Hard CVD Events in Obese Patients With Type 2 Diabetes

Michael O'Riordan

October 18, 2018

News Features

Survey Says: Interventional Cardiologists Still Divided Over Appropriate Use Criteria

Caitlin E. Cox

October 18, 2018

Advertisement

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

Endoscopic Vein-Graft Harvest for CABG Associated With Similar MACE, Less Pain vs Open Procedure: REGROUP

Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients

T-Time: Alteplase Infusion No Help for Failed Reperfusion in STEMI PCI

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides

VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer

Race May Be a Proxy for Many Disparities in CVD Treatment, Outcomes

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

High-Sensitivity Troponin Assays May Help Cut Down on Unnecessary Stress Tests, Study Suggests

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Lingering Signs of Inflammation Post-PCI Signal More Death, MI at 1 Year

A Look Back at TCT 2018: What I Took Away From the Meeting

Bariatric Surgery Reduces Hard CVD Events in Obese Patients With Type 2 Diabetes

Survey Says: Interventional Cardiologists Still Divided Over Appropriate Use Criteria

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content